middle.news
How Will EBR Systems Scale After $1.6M Revenue and FDA Approval in 2025?
8:34am on Thursday 19th of March, 2026 AEDT
•
Healthcare
Read Story
How Will EBR Systems Scale After $1.6M Revenue and FDA Approval in 2025?
8:34am on Thursday 19th of March, 2026 AEDT
Key Points
FDA approval of WiSE CRT System in April 2025
Initiation of U.S. commercial implants and $1.6 million revenue
CMS reimbursement pathways established with $63,300 contract price
Commencement of post-approval and feasibility clinical studies
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
EBR SYSTEMS (ASX:EBR)
OPEN ARTICLE